F054 Putting Technology to Work for You and Your Patients: Augmented Intelligence and its Role in Enhancing the Practice of Dermatology
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
This session is directed at clinicians who seek to further understand the current state and future potential of technology, including AI/AuI, in their care of patients. The area of Artificial Intelligence (AI) and Augmented Intelligence (AuI) is undergoing rapid development and advancement and has already begun to impact the practice of medicine and dermatologic care including the administrative aspect and burdens. Technology holds the potential to enhance access to high-quality, patient-centered, dermatologist-led care. We believe in the central role of clinicians and patients in the development of and responsible use of these data-driven tools and systems to enhance human intelligence and the care experience for clinicians, staff and patients alike.
LEARNING OBJECTIVES
Define the concept of artificial intelligence (AI) vs. augmented intelligence (AuI) and assess knowledge, expectations, biases and fears of these tools and systems
Examine the methods and concepts that underlie this technology, characteristics of high-quality AI/AuI, risks and challenges to overcome, and the importance of efficient and effective integration into practice to achieve clinical benefit
Recognize use cases and examples of AI/AuI innovations that have the potential to positively impact how clinicians deliver care and evaluate AI/AuI technology and determine the fit for their practice/patients
SCHEDULE
9:00 PM
Session Introduction: Are We There Yet?
Justin Ko, MD, MBA, FAAD
9:10 PM
DermGPT: How a language model based AI can improve clinic flow and practice management
Faranak Kamangar, MD, FAAD
9:30 PM
AI-powered Clinical-decision Making
Alexander Witkowski, PhD, MD
9:50 PM
AI-powered documentation and potential in procedural and cosmetic dermatology
Jane Y Yoo, MD, MPP, FAAD
10:10 PM
The role of AI-powered for the future of dermatology education
Arlene M. Ruiz de Luzuriaga, MD, FAAD
10:30 PM
Moderated Panel Discussion and Audience Q&A
SPEAKERS
Faranak Kamangar, MD, FAAD
Justin Ko, MD, MBA, FAAD
Arlene M. Ruiz de Luzuriaga, MD, FAAD
Alexander Witkowski, PhD, MD
Jane Y Yoo, MD, MPP, FAAD
HANDOUTS
SPEAKER DISCLOSURES
Faranak Kamangar, MD, FAAD
No financial relationships exist with ineligible companies.
Justin Ko, MD, MBA, FAAD
Eli Lilly and Company – Consultant(Fees); Enspectra Health – Consultant(Fees), Consultant(Stock Options); Google Research – Investigator(Grants/Research Funding); Hims – Consultant(Fees); Pfizer Inc. – Consultant(Fees); Skin Analytics – Advisory Board(Stock Options), Consultant(Fees);
Arlene M. Ruiz de Luzuriaga, MD, FAAD
No financial relationships exist with ineligible companies.
Alexander Witkowski, PhD, MD
No financial relationships exist with ineligible companies.
Jane Y Yoo, MD, MPP, FAAD
Arcutis, Inc. – Advisory Board(Honoraria); AVAVA, LLC – Consultant (1099 relationship)(Honoraria); Castle Biosciences – Advisory Board(Honoraria), Speaker(Honoraria); Lumenis – Consultant (1099 relationship)(Honoraria); SkinCeuticals LLC – Advisory Board(Honoraria);